Investigation Report on China Desloratadine Market, 2010-2019
Histamine, a substance which can lead to inflammation and anaphylaxis, is one of the important chemical mediators of immediate anaphylaxis (the most common type I allergy in clinic). The incidence of allergy has always been high and shows an increasing trend. According to the American Acadymy of Allergy, Asthma and Immunology, allergy has become the sixth chronic disease in the US with 20%-40% of the total population suffering from it. According to the statistics, the number of cases of allergic rhinitis in China exceeds 100 million and the incidence of allergic disease has reached about 30%. For a long time, anti-histamine has been widely used for the desensitization treatment of allergic diseases especially allergic rhinitis and urticaria. Among all the patients with dermatosis in hospitals, those suffering from allergic dermatosis account for 30%. And 70% of them need anti-histamine, one representative of which is desloratadine. Developed by Sepracor and Schering-Plough, desloratadine first entered the British market in Feb. 2201 and has now become a top-selling drug in the world.
Local enterprises in China started developing the generic drugs of desloratadine early. In 2002, Hainan Poly Pharm Co., Ltd, Shenzhen Haibin Pharmaceutical Co., Ltd and Salubris were all approved by CFDA to produce desloratadine’s Active Pharmaceutical Ingredients (APIs) and tablets. Desloratadine develops fast after entering China with annual sales value rising from less than CNY 12 million in 2005 to CNY 185 million in 2014 and CAGR reaching up to 36% during the period of 2005-2014. Desloratadine enjoys a vast demand in China. Hainan Poly Pharm Co., Ltd, Hairui Pharmaceutical, Nanjing Hicin Pharmaceutical Co., Ltd, Shenzhen Haibin Pharmaceutical Co., Ltd and Salubris all take up certain shares in the market, among which Hairui Pharmaceutical has the largest market share of over 55% in 2014 for sales value while Hainan Poly Pharm Co., Ltd has the largest market share of 32.3% for sales volume.
The market size of desloratadine in China is expected to keep growing in the next few years.
Readers can get at least the following information from this report:
market size of desloratadine in China
market share of manufacturers of desloratadine in China
price of desloratadine in Chinese market
major manufacturers of desloratadine in Chinese market
market outlook of desloratadine in China
The author suggests the following groups of people purchase this report:
manufacturers of anti-histammmines
investors/ research institutions interested in Chinese medicine market
any interest in the Chinese medicine market, please contact CRI for customized survey service
Please Note: All reports from China Research and Intelligence are written in Chinese, then translated to English. This process takes approximately 5 business days from the date the order is placed